Woodline Partners’s Envoy Medical Warrant COCHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-224,999
Closed -$22K 767
2022
Q2
$22K Hold
224,999
﹤0.01% 665
2022
Q1
$56K Buy
224,999
+66,666
+42% +$28.7K ﹤0.01% 582
2021
Q4
$122K Hold
158,333
﹤0.01% 598
2021
Q3
$100K Hold
158,333
﹤0.01% 586
2021
Q2
$147K Buy
+158,333
New +$113K ﹤0.01% 493

Other funds holding COCHW

Woodline Partners's COCHW Position: Q3 2022 in Review

Woodline Partners sold out of Envoy Medical Warrant (COCHW) in Q3 2022, closing a stake of 224,999 shares — an estimated $22K sold.

Woodline Partners first reported a position in COCHW in Q2 2021 and held it in 5 quarters. The position peaked at $147K in Q2 2021. 57 funds tracked by Wall St. Rank hold COCHW as of Q3 2022.

  • Woodline Partners reported no remaining Envoy Medical Warrant position as of Q3 2022 after selling out during the quarter.
  • Woodline Partners sold 224,999 Envoy Medical Warrant shares in Q3 2022, an estimated $22K.
  • Woodline Partners first reported a position in Envoy Medical Warrant in Q2 2021 and held it in 5 quarters.
  • Woodline Partners's Envoy Medical Warrant position peaked at $147K in Q2 2021.
  • 57 funds tracked by Wall St. Rank held Envoy Medical Warrant as of Q3 2022.

Based on Woodline Partners's 13F filing for Q3 2022, filed 14 Nov 2022.